Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer Agnihotri

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Neurobiology of Disease|July 6, 2011
Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiformeAmparo Wolf, Sameer Agnihotri, Diana Munoz, et al.
Nature Cancer|February 5, 2022
A vaccine for gliomaSameer Agnihotri, Kailin Yang, Duane A Mitchell, et al.
Journal of Visualized Experiments : Jove|June 25, 2013
A novel high-resolution in vivo imaging technique to study the dynamic response of intracranial structures to tumor growth and therapeuticsKelly Burrell, Sameer Agnihotri, Michael Leung, et al.
Neuro-Oncology Advances|January 20, 2022
The dominant TP53 hotspot mutation in <b></b> -mutant astrocytoma, R273C, has distinctive pathologic features and sex-specific prognostic implicationsDaniel F Marker, Sameer Agnihotri, Nduka Amankulor, et al.
Neuro-Oncology Advances|May 8, 2023
Pediatric diffuse midline glioma: Understanding the mechanisms and assessing the next generation of personalized therapeuticsNicolina Jovanovich, Ahmed Habib, Jeffery Head, et al.
Nature Reviews. Cancer|June 17, 2022
Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneityRyan C Gimple, Kailin Yang, Matthew E Halbert, et al.
The Journal of Molecular Diagnostics : JMD|September 5, 2017
Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas DataYasin Mamatjan, Sameer Agnihotri, Anna Goldenberg, et al.
Plos One|June 30, 2012
Investigation of the in vitro therapeutic efficacy of nilotinib in immortalized human NF2-null vestibular schwannoma cellsNesrin Sabha, Karolyn Au, Sameer Agnihotri, et al.
Glia|September 17, 2013
Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent mannerDiana Marcela Muñoz, Takyee Tung, Sameer Agnihotri, et al.
Endocrine-Related Cancer|July 24, 2014
The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomasEric Monsalves, Kyle Juraschka, Toru Tateno, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Neurobiology of Disease|July 6, 2011
Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiformeAmparo Wolf, Sameer Agnihotri, Diana Munoz, et al.
Nature Cancer|February 5, 2022
A vaccine for gliomaSameer Agnihotri, Kailin Yang, Duane A Mitchell, et al.
Journal of Visualized Experiments : Jove|June 25, 2013
A novel high-resolution in vivo imaging technique to study the dynamic response of intracranial structures to tumor growth and therapeuticsKelly Burrell, Sameer Agnihotri, Michael Leung, et al.
Neuro-Oncology Advances|January 20, 2022
The dominant TP53 hotspot mutation in <b></b> -mutant astrocytoma, R273C, has distinctive pathologic features and sex-specific prognostic implicationsDaniel F Marker, Sameer Agnihotri, Nduka Amankulor, et al.
Neuro-Oncology Advances|May 8, 2023
Pediatric diffuse midline glioma: Understanding the mechanisms and assessing the next generation of personalized therapeuticsNicolina Jovanovich, Ahmed Habib, Jeffery Head, et al.
Nature Reviews. Cancer|June 17, 2022
Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneityRyan C Gimple, Kailin Yang, Matthew E Halbert, et al.
The Journal of Molecular Diagnostics : JMD|September 5, 2017
Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas DataYasin Mamatjan, Sameer Agnihotri, Anna Goldenberg, et al.
Plos One|June 30, 2012
Investigation of the in vitro therapeutic efficacy of nilotinib in immortalized human NF2-null vestibular schwannoma cellsNesrin Sabha, Karolyn Au, Sameer Agnihotri, et al.
Glia|September 17, 2013
Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent mannerDiana Marcela Muñoz, Takyee Tung, Sameer Agnihotri, et al.
Endocrine-Related Cancer|July 24, 2014
The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomasEric Monsalves, Kyle Juraschka, Toru Tateno, et al.
Pageof 13